China Biologic Products Holdings (CBPO) EBITDA US GAAP (year values)

2016 2017 2018 2019 2020   LTM ? CAGR 5 years ?
EBITDA, bln rub ? 142.9 145.6 169.7 193.7 215.5   215.5  
Changes by years, y/y, % +18% +2% +17% +14% +11%     +12.3%

China Biologic Products Holdings. EBITDA US GAAP, bln rub

China Biologic Products Holdings. EBITDA US GAAP, changes, %

China Biologic Products Holdings. EBITDA US GAAP, sum by quarters, bln rub

China Biologic Products Holdings (CBPO) EBITDA US GAAP (quarter values)

2019Q4 2020Q1 2020Q2 2020Q3 2020Q4   LTM ?
EBITDA, bln rub ? 24.3 71.7 48.9 56.1 38.7   215.5
Changes by years, y/y, % -50% +38% -13% -8% +59%    
Changes by quarters, q/q, % -60% +195% -32% +15% -31%    

China Biologic Products Holdings. EBITDA US GAAP, bln rub

China Biologic Products Holdings. EBITDA US GAAP, changes, y/y, %

China Biologic Products Holdings. EBITDA US GAAP, changes, q/q, %